2000
DOI: 10.1016/s0924-8579(99)00165-x
|View full text |Cite
|
Sign up to set email alerts
|

CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
196
0
5

Year Published

2003
2003
2016
2016

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 242 publications
(214 citation statements)
references
References 23 publications
11
196
0
5
Order By: Relevance
“…Interestingly, intermediate or highlevel resistance to amoxicillin-clavulanate was more common among CTX-M producers (96.4% of E. coli isolates and 90.8% of K. pneumoniae isolates) than among strains producing non-CTX-M-type ESBLs (80.0% of E. coli isolates and 75.8% of K. pneumoniae isolates), whereas resistance to piperacillin-tazobactam was conversely less frequent among CTX-M producers (17.9% of E. coli isolates and 37.9% of K. pneumoniae isolates) than among strains producing non-CTX-M-type ESBLs (36.0% of E. coli isolates and 48.4% of K. pneumoniae isolates). The greater activity of piperacillin-tazobactam against CTX-M-positive strains is probably explained by the fact that the CTX-M enzymes are better inhibited by tazobactam than by clavulanate (10,35,37).…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, intermediate or highlevel resistance to amoxicillin-clavulanate was more common among CTX-M producers (96.4% of E. coli isolates and 90.8% of K. pneumoniae isolates) than among strains producing non-CTX-M-type ESBLs (80.0% of E. coli isolates and 75.8% of K. pneumoniae isolates), whereas resistance to piperacillin-tazobactam was conversely less frequent among CTX-M producers (17.9% of E. coli isolates and 37.9% of K. pneumoniae isolates) than among strains producing non-CTX-M-type ESBLs (36.0% of E. coli isolates and 48.4% of K. pneumoniae isolates). The greater activity of piperacillin-tazobactam against CTX-M-positive strains is probably explained by the fact that the CTX-M enzymes are better inhibited by tazobactam than by clavulanate (10,35,37).…”
Section: Resultsmentioning
confidence: 99%
“…Accurate sizing of PCR products has been used for Mycobacterium tuberculosis typing and PCR product analysis to differentiate AmpC â-lactamases (Evans et al, 2004;PerezPerez & Hanson, 2002;Tzouvelekis et al, 2000). The application of the DHPLC WAVE technology to the analysis of multiplex PCR products developed in this study has clear advantages.…”
Section: Evaluation Of Multiplex Pcr With Clinical Isolatesmentioning
confidence: 96%
“…The sequences from six strains, three from group 8 (CTX-M-8, CTX-M-40 and CTX-M-41) and three from group 25/26 (CTX-M-25, -26 and -39), were aligned together. They have previously all been classified within group 8 (Tzouvelekis et al, 2000) and consequently this study will identify groups 8 and 25/26 as one group. The group-specific primer sets were designed in the highly conserved region of the alignments.…”
Section: Identification Of Bla Ctx-m Subgroup-specific Primersmentioning
confidence: 99%
“…Rather than arising by mutation, they represent examples of plasmid acquisition of the b lactamases genes which are found on the chromosomes of the Kluyvera species. CTX-M was 1st detected in E.coli strains in Germany (1988) and presently, there are more than 65 allelic variants which are known [2,3].…”
Section: Microbiology Sectionmentioning
confidence: 99%